levonorgestrel has been researched along with Phlegmasia Alba Dolens in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bistervels, IM; Hamulyák, EN; Middeldorp, S; Scheres, LJJ | 1 |
| Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Weiss, NS | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Helmerhorst, F; Vandenbroucke, JP | 1 |
1 review(s) available for levonorgestrel and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low-Molecular-Weight; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Risk Factors; Sex Factors; Stockings, Compression; Thrombophilia; Thrombophlebitis; Tranexamic Acid; Travel; Uterine Hemorrhage; Venous Thromboembolism; Young Adult | 2019 |
5 other study(ies) available for levonorgestrel and Phlegmasia Alba Dolens
| Article | Year |
|---|---|
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis | 1995 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Bias; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Research Design; Thrombophlebitis | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
[Third-generation pill].
Topics: Adult; Contraception; Contraceptives, Oral, Synthetic; Contraindications; Counseling; Desogestrel; Female; Humans; Levonorgestrel; Netherlands; Risk Assessment; Secondary Prevention; Thrombophlebitis | 2000 |